Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000222582 | SCV000272920 | uncertain significance | not specified | 2016-12-22 | criteria provided, single submitter | clinical testing | The p.Leu854Phe variant in WFS1 has been previously identified by our laboratory in one individual with hearing loss. This variant has also been identified in 2 /6596 Finnish chromosomes and 2/65330 European chromosomes by the Exome Aggregat ion Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs771391168). Althou gh this variant has been seen in the general population, its frequency is not hi gh enough to rule out a pathogenic role. Computational prediction tools and cons ervation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Leu854Phe variant is unc ertain. |
Fulgent Genetics, |
RCV002478782 | SCV002781251 | uncertain significance | Cataract 41; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome | 2022-04-28 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV003148683 | SCV003804408 | uncertain risk allele | Wolfram syndrome 1 | criteria provided, single submitter | research | Potent mutations in WFS1 gene are associated with Wolfram's syndrome, an autosomal recessive condition, which cause diabetes mellitus, diabetes insipidus, deafness and optic atrophy. However no sufficient evidence is found to ascertain the role of this particular variant rs771391168 in Wolfram's syndrome yet. |